Ethchlorvynol

Uses your system voice; voice and rate in settings.

Snapshot

≈ 2 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Ethchlorvynol is a GABA A receptor positive allosteric modulator with hypnotic and sedative properties, first developed by Pfizer in the 1950s. In the United States, it was sold by Abbott Laboratories under the trade name Placidyl. Placidyl was available in 200 mg, 500 mg, and 750 mg strength gel-filled capsules. The 500 mg and 750 mg capsules were intended to reduce sleep latency, while the 200 mg capsule was intended to re-induce sleep in cases of early awakening. Abbott discontinued production in 1999, largely because benzodiazepines (such as Librium and Valium) had replaced non-barbiturate sedatives in clinical practice; by the end of 2001 remaining supplies in the United States had been exhausted.

Ethchlorvynol is a GABA A receptor positive allosteric modulator with hypnotic and sedative properties, first developed by Pfizer in the 1950s. In the United States, it was sold by Abbott Laboratories under the trade name Placidyl. Placidyl was available in 200 mg, 500 mg, and 750 mg strength gel-filled capsules. The 500 mg and 750 mg capsules were intended to reduce sleep latency, while the 200 mg capsule was intended to re-induce sleep in cases of early awakening. Abbott discontinued production in 1999, largely because benzodiazepines (such as Librium and Valium) had replaced non-barbiturate sedatives in clinical practice; by the end of 2001 remaining supplies in the United States had been exhausted.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1373297741 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

11 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.